{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T11:57:31Z","timestamp":1762862251322,"version":"build-2065373602"},"reference-count":26,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T00:00:00Z","timestamp":1647561600000},"content-version":"vor","delay-in-days":382,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["slas-discovery.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["SLAS Discovery"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1177\/2472555220975672","type":"journal-article","created":{"date-parts":[[2020,12,3]],"date-time":"2020-12-03T02:35:47Z","timestamp":1606962947000},"page":"345-351","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["COMPARE Analysis, a Bioinformatic Approach to Accelerate Drug Repurposing against Covid-19 and Other Emerging Epidemics"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3294-1126","authenticated-orcid":false,"given":"Imad","family":"Naasani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1177\/2472555220975672_bib1","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1093\/jnci\/81.14.1088","article-title":"Display and Analysis of Patterns of Differential Activity of Drugs against Human Tumor Cell Lines: Development of Mean Graph and COMPARE Algorithm","volume":"81","author":"Paull","year":"1989","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1177\/2472555220975672_bib2","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/jnci\/83.11.757","article-title":"Feasibility of a High-Flux Anticancer Drug Screen Using a Diverse Panel of Cultured Human Tumor Cell Lines","volume":"83","author":"Monks","year":"1991","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1177\/2472555220975672_bib3","first-page":"129","article-title":"A Human Cell Line Panel for Screening Anti-Cancer Drugs","volume":"24","author":"Yamori","year":"1997","journal-title":"Gan To Kagaku Ryoho"},{"key":"10.1177\/2472555220975672_bib4","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1126\/science.275.5298.343","article-title":"An Information-Intensive Approach to the Molecular Pharmacology of Cancer","volume":"275","author":"Weinstein","year":"1997","journal-title":"Science (New York, N.Y.)"},{"key":"10.1177\/2472555220975672_bib5","first-page":"4004","article-title":"FJ5002: A Potent Telomerase Inhibitor Identified by Exploiting the Disease-Oriented Screening Program with COMPARE Analysis","volume":"59","author":"Naasani","year":"1999","journal-title":"Cancer Res."},{"key":"10.1177\/2472555220975672_bib6","first-page":"197","article-title":"Screening with COMPARE Analysis for Telomerase Inhibitors","volume":"191","author":"Naasani","year":"2002","journal-title":"Methods Mol. Biol."},{"key":"10.1177\/2472555220975672_bib7","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/nprot.2006.179","article-title":"Sulforhodamine B Colorimetric Assay for Cytotoxicity Screening","volume":"1","author":"Vichai","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1177\/2472555220975672_bib8","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1091\/mbc.02-02-0030","article-title":"Identification of Genes Periodically Expressed in the Human Cell Cycle and Their Expression in Tumors","volume":"13","author":"Whitfield","year":"2002","journal-title":"Mol. Biol. Cell."},{"key":"10.1177\/2472555220975672_bib9","doi-asserted-by":"crossref","first-page":"4977","DOI":"10.1021\/jm4004285","article-title":"QSAR Modeling: Where Have You Been? Where Are You Going To?","volume":"57","author":"Cherkasov","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1177\/2472555220975672_bib10","doi-asserted-by":"crossref","first-page":"8666","DOI":"10.1038\/s41598-019-44981-y","article-title":"Mechanistic Study of PpIX Accumulation Using the JFCR39 Cell Panel Revealed a Role for Dynamin 2-Mediated Exocytosis","volume":"9","author":"Kitajima","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1177\/2472555220975672_bib11","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ejmech.2012.03.026","article-title":"Synthesis, Evaluation of Anticancer Activity and COMPARE Analysis of N-Bis(trifluoromethyl)alkyl-N\u2032-Substituted Ureas with Pharmacophoric Moieties","volume":"53","author":"Luzina","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1177\/2472555220975672_bib12","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00483-20","article-title":"Updated Approaches against SARS-CoV-2","volume":"64","author":"Li","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"doi-asserted-by":"crossref","unstructured":"Gorshkov K., Chen C. Z., Bostwick R.; et al. The SARS-CoV-2 Cytopathic Effect Is Blocked with Autophagy Modulators. bioRxiv 2020. 10.1101\/2020.05.16.091520.","key":"10.1177\/2472555220975672_bib13","DOI":"10.1101\/2020.05.16.091520"},{"key":"10.1177\/2472555220975672_bib14","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0968-0896(02)00542-4","article-title":"Inhibitory Effects of Lapachol Derivatives on Epstein-Barr Virus Activation","volume":"11","author":"Sacau","year":"2003","journal-title":"Bioorg. Med. Chem."},{"key":"10.1177\/2472555220975672_bib15","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S1043-6618(05)80070-2","article-title":"Pharmacology and Clinical Use of a New Group of Antiarrhythmic Drugs: Derivatives of Tricyclic Nitrogen-Containing Systems","volume":"25","author":"Kaverina","year":"1992","journal-title":"Pharmacol. Res."},{"key":"10.1177\/2472555220975672_bib16","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3390\/ph13030051","article-title":"Emetine, Ipecac, Ipecac Alkaloids and Analogues as Potential Antiviral Agents for Coronaviruses","volume":"13","author":"Bleasel","year":"2020","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1177\/2472555220975672_bib17","doi-asserted-by":"crossref","first-page":"104786","DOI":"10.1016\/j.antiviral.2020.104786","article-title":"Remdesivir, Lopinavir, Emetine, and Homoharringtonine Inhibit SARS-CoV-2 Replication In Vitro","volume":"178","author":"Choy","year":"2020","journal-title":"Antiviral Res."},{"doi-asserted-by":"crossref","unstructured":"Riva L., Yuan S., Yin X.; et al. A Large-Scale Drug Repositioning Survey for SARS-CoV-2 Antivirals. bioRxiv 2020. DOI: 10.1101\/2020.04.16.044016.","key":"10.1177\/2472555220975672_bib18","DOI":"10.1101\/2020.04.16.044016"},{"key":"10.1177\/2472555220975672_bib19","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/s41586-020-2286-9","article-title":"A SARS-CoV-2 Protein Interaction Map Reveals Targets for Drug Repurposing","volume":"583","author":"Gordon","year":"2020","journal-title":"Nature"},{"key":"10.1177\/2472555220975672_bib20","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1111\/1440-1681.13354","article-title":"A Role for Retinoids in the Treatment of COVID-19?","volume":"47","author":"Trasino","year":"2020","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1177\/2472555220975672_bib21","doi-asserted-by":"crossref","first-page":"104960","DOI":"10.1016\/j.phrs.2020.104960","article-title":"Discovery of the FDA-Approved Drugs Bexarotene, Cetilistat, Diiodohydroxyquinoline, and Abiraterone as Potential COVID-19 Treatments with a Robust Two-Tier Screening System","volume":"159","author":"Yuan","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1177\/2472555220975672_bib22","doi-asserted-by":"crossref","first-page":"338","DOI":"10.3390\/v11040338","article-title":"Mechanism of Action of Methotrexate against Zika Virus","volume":"11","author":"Beck","year":"2019","journal-title":"Viruses"},{"key":"10.1177\/2472555220975672_bib23","doi-asserted-by":"crossref","first-page":"102468","DOI":"10.1016\/j.jaut.2020.102468","article-title":"The Anti-Viral Facet of Anti-Rheumatic Drugs: Lessons from COVID-19","volume":"111","author":"Perricone","year":"2020","journal-title":"J. Autoimmun."},{"key":"10.1177\/2472555220975672_bib24","doi-asserted-by":"crossref","first-page":"4885","DOI":"10.1128\/AAC.03036-14","article-title":"Repurposing of Clinically Developed Drugs for Treatment of Middle East Respiratory Syndrome Coronavirus Infection","volume":"58","author":"Dyall","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1177\/2472555220975672_bib25","doi-asserted-by":"crossref","first-page":"53","DOI":"10.31254\/phyto.2017.6108","article-title":"A Review on Pharmacological Potential of Berberine; an Active Component of Himalayan Berberis aristata","volume":"6","author":"Chander","year":"2017","journal-title":"J. Phytopharmacol."},{"key":"10.1177\/2472555220975672_bib26","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.sjbs.2015.01.011","article-title":"Anti-influenza (H1N1) potential of leaf and stem bark extracts of selected medicinal plants of South India","volume":"22","author":"Enkhtaivan","year":"2015","journal-title":"Saudi J. Biol. Sci."}],"container-title":["SLAS Discovery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/2472555220975672","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/2472555220975672","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2472555222066916?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2472555222066916?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/2472555220975672","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T11:53:14Z","timestamp":1762861994000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2472555222066916"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S2472555222066916"],"URL":"https:\/\/doi.org\/10.1177\/2472555220975672","relation":{},"ISSN":["2472-5552"],"issn-type":[{"type":"print","value":"2472-5552"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"COMPARE Analysis, a Bioinformatic Approach to Accelerate Drug Repurposing against Covid-19 and Other Emerging Epidemics","name":"articletitle","label":"Article Title"},{"value":"SLAS Discovery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1177\/2472555220975672","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2021 Society for Laboratory Automation and Screening. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}